Stanley Erck
Vermogen: 450 186 $ op 31-07-2026
Vermogen: 450 186 $ op 31-07-2026
De heer Stanley C. Erck is President, Chief Executive Officer & Director bij Novavax, Inc. en een onafhankelijk niet-uitvoerend bestuurder bij MaxCyte, Inc. Hij zit in de Raad van Bestuur van Novavax, Inc., MdBio Foundation en MaxCyte, Inc. De heer Erck was voorheen werkzaam als Onafhankelijk Bestuurder bij BioCryst Pharmaceuticals, Inc., President, Chief Executive Officer & Bestuurder bij Iomai Corp., Hoofd-Global Regulatory Affairs Vaccines bij Baxter International, Inc., Vice President-Corporate Development bij Integrated Genetics, Inc., en President, Chief Executive Officer & Bestuurder bij Procept, Inc. Hij behaalde zijn doctoraal aan de Universiteit van Illinois en een MBA aan The University of Chicago Booth School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MAXCYTE, INC. 0,4% | 17-06-2026 | 428.749 ( 0,4% ) | 450 186 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MAXCYTE, INC. | Directeur/Bestuurslid | 01-01-2005 |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Bestuurslid | 13-05-2009 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVAVAX, INC. | Algemeen Directeur | 23-01-2023 |
| BIOCRYST PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 03-12-2018 |
| IOMAI CORPORATION | Algemeen Directeur | 01-01-2008 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Corporate Officer/Principal | - |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Kies jouw editie
Alle financiële informatie op nationaal niveau